Arcutis to Present at the Wedbush PacGrow Healthcare Conference
August 10 2020 - 9:00AM
Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage
biopharmaceutical company focused on developing and commercializing
treatments for unmet needs in immune-mediated dermatological
diseases and conditions, or immuno-dermatology, today announced
that Arcutis management will participate in a presentation during
the Wedbush PacGrow Healthcare Conference Webcast taking place
August 11 - 12, 2020.
Details for the presentation are as
follows:
Wedbush PacGrow Healthcare
Conference
Presentation Date: Wednesday, August 12,
2020
Presentation Time: 10:10 a.m. PT / 1:10 p.m.
ET
The presentation will be webcast and may be
accessed at the “Events & Presentations” section of the
Company’s website at
https://investors.arcutis.com/events-and-presentations. Arcutis
will maintain an archived replay of the webcast on its website for
30 days after the conference.
About Arcutis - Bioscience,
applied to the skin.Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is
a late-stage biopharmaceutical company focused on developing and
commercializing treatments for unmet needs in immune-mediated
dermatological diseases and conditions, or immuno-dermatology. The
company is leveraging recent advances in immunology and
inflammation to develop differentiated therapies against
biologically validated targets to solve persistent treatment
challenges in serious diseases of the skin. Arcutis’ robust
pipeline includes four novel drug candidates currently in
development for a range of inflammatory dermatological conditions.
The company’s lead product candidate, topical roflumilast, has the
potential to revitalize the standard of care for plaque psoriasis,
atopic dermatitis, scalp psoriasis, and seborrheic dermatitis. For
more information, visit https://www.arcutis.com or follow the
company on LinkedIn and Twitter.
Investors and Media:Heather Rowe ArmstrongVice
President, Investor Relations & Corporate
Communicationsharmstrong@arcutis.com805-418-5006, Ext. 740
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arcutis Biotherapeutics (NASDAQ:ARQT)
Historical Stock Chart
From Apr 2023 to Apr 2024